Structure Therapeutics Inc. American Depositary Shares (GPCR)
PHARMACEUTICAL PREPARATIONS
Structure Therapeutics Inc. American Depositary Shares (GPCR) is listed on Nasdaq, where it has traded since February 3, 2023.
- Listed On
- Nasdaq
- Listed Since
- February 3, 2023
- Employees
- 281
- Market Cap
- $1.5B
About Structure Therapeutics Inc. American Depositary Shares
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 190 institutions reported holding GPCR, with 67.5 million shares worth $3.6 billion in aggregate. The largest reported holder was FMR, with 7.8 million shares worth $419.2 million. Of the 5 largest holders listed below, 2 added shares, 2 reduced their positions and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| FMR | 7,810,306 | $419M | Reduced 7.06% |
| Wellington Management | 7,379,433 | $396M | Added 1.64% |
| Avoro Capital Advisors | 6,555,555 | $352M | Unchanged |
| Janus Henderson (Jupiter Topco) | 5,204,212 | $279M | Reduced 2.82% |
| Deep Track Capital | 4,740,072 | $254M | Added 10.75% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is GPCR?
Structure Therapeutics Inc. American Depositary Shares (GPCR) is listed on Nasdaq, where it has traded since February 3, 2023.
Who are the largest institutional holders of GPCR?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of GPCR were FMR, Wellington Management and Avoro Capital Advisors.
How many institutions own GPCR?
190 institutions reported a position in GPCR for the quarter ended June 30, 2026, worth $3.6 billion in total.
Did institutions buy or sell GPCR last quarter?
Of the 5 largest reported holders, 2 added shares, 2 reduced their positions and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for GPCR.
Every reported institutional holder, plus insider and congressional trades in GPCR, on SentiSense.